Sign inGet started

Moses Alan Charles

Insider CIK 1819501 · CMMB Director · PHGE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PHGE BiomX Inc. A Award deriv2025-04-142025-04-1817,600— $017,600SEC↗
PHGE BiomX Inc. A Award deriv2025-04-142025-04-2117,600— $017,600SEC↗
PHGE BiomX Inc. A Award deriv2024-07-112024-07-15176,000— $0176,000SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2023-03-162023-03-236,857— $06,857SEC↗
PHGE BiomX Inc. A Award deriv2023-03-012023-03-0341,000— $041,000SEC↗
PHGE BiomX Inc. A Award deriv2022-03-292022-03-3120,500— $020,500SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2022-03-072023-03-236,820— $06,820SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2022-03-072022-03-096,820— $06,820SEC↗
PHGE BiomX Inc. P Buy deriv2021-07-282021-07-303,750— $03,750SEC↗
PHGE BiomX Inc. P Buy2021-07-282021-07-305,000$4.00 $20.0K5,000SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2021-04-192023-03-2311,884— $011,884SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2021-04-192022-03-0911,884— $011,884SEC↗
CMMB Chemomab Therapeutics Ltd. A Award deriv2021-04-192021-04-2111,884— $011,884SEC↗
PHGE BiomX Inc. A Award deriv2021-03-302021-04-0115,200— $015,200SEC↗
PHGE BiomX Inc. A Award deriv2020-10-022020-10-0516,000— $016,000SEC↗